{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:38:04Z","timestamp":1792715884668,"version":"4.5.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: CardioOncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jaccao.2026.08.006","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:30:36Z","timestamp":1792524636000},"page":"507-511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-Term Cardiovascular Care After Cytokine Release Syndrome"],"prefix":"10.1016","volume":"8","author":[{"given":"Bel\u00e9n","family":"Terol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Mart\u00edn-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8364-3447","authenticated-orcid":false,"given":"Dimitrios","family":"Farmakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Eiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"S\u00e1nchez Vadillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"C\u00f3rdoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3414-7022","authenticated-orcid":false,"given":"Teresa","family":"Lopez-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"41","key":"10.1016\/j.jaccao.2026.08.006_bib1","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"issue":"25","key":"10.1016\/j.jaccao.2026.08.006_bib2","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/j.jacc.2019.10.038","article-title":"Cardiovascular events among adults treated with chimeric antigen receptor T-Cells (CAR-T)","volume":"74","author":"Alvi","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jaccao.2026.08.006_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jaccao.2020.04.012","article-title":"Cardiovascular effects of CAR T cell therapy","volume":"2","author":"Lefebvre","year":"2020","journal-title":"JACC CardioOncol"},{"issue":"10","key":"10.1016\/j.jaccao.2026.08.006_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.37222","article-title":"Cardiovascular events after chimeric antigen receptor T-Cell therapy for advanced hematologic malignant neoplasms: a meta-analysis","volume":"7","author":"Koeckerling","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.jaccao.2026.08.006_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/ejh.70040","article-title":"Predictive factors and baseline risk stratification for CAR -T cell therapy-related cardiovascular toxicity","volume":"116","author":"Farmakis","year":"2026","journal-title":"Eur J Haematol"},{"issue":"22","key":"10.1016\/j.jaccao.2026.08.006_bib6","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/eurheartj\/ehad117","article-title":"Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients","volume":"44","author":"Mahmood","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2026.08.006_bib7","article-title":"Chimeric antigen receptor T-cell therapy and cardiovascular outcomes in US Medicare beneficiaries","volume":"26","author":"Zaghlol","year":"2026","journal-title":"Eur Heart J"},{"issue":"17","key":"10.1016\/j.jaccao.2026.08.006_bib8","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/CIRCULATIONAHA.120.048100","article-title":"Chimeric antigen receptor T-Cell therapy\u2013associated cardiomyopathy in patients with refractory or relapsed non-hodgkin lymphoma","volume":"142","author":"Ganatra","year":"2020","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.jaccao.2026.08.006_bib9","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1161\/CIRCULATIONAHA.124.070432","article-title":"Cardiovascular complications and their association with Short- and long-term outcomes in patients with multiple myeloma and lymphoma undergoing chimeric antigen receptor T-Cell therapy","volume":"150","author":"Itzhaki Ben Zadok","year":"2024","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jaccao.2026.08.006_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/bjh.70216","article-title":"Cardiovascular complications and their association with short- and long-term outcomes in patients with multiple myeloma undergoing chimeric antigen receptor T-cell therapy","volume":"208","author":"Itzhaki Ben Zadok","year":"2026","journal-title":"Br J Haematol"}],"container-title":["JACC: CardioOncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087326003054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087326003054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:43:59Z","timestamp":1792712639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666087326003054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2666087326003054"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccao.2026.08.006","relation":{},"ISSN":["2666-0873"],"issn-type":[{"value":"2666-0873","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Cardiovascular Care After Cytokine Release Syndrome","name":"articletitle","label":"Article Title"},{"value":"JACC: CardioOncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccao.2026.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}